Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Glucagon-receptor-antagonism-mediated β-cell regeneration as an effective anti-diabetic therapy.
Journal: Cell reports
Published: April 16, 2021
Therapeutic FGF19 promotes HDL biogenesis and transhepatic cholesterol efflux to prevent atherosclerosis.
Journal: Journal of lipid research
Published: September 19, 2018
Engineered FGF19 eliminates bile acid toxicity and lipotoxicity leading to resolution of steatohepatitis and fibrosis in mice.
Journal: Hepatology communications
Published: July 10, 2017
Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15.
Journal: Journal of hepatology
Published: October 25, 2016
Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis.
Journal: Nature communications
Published: August 01, 2016
Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2-deficient mice.
Journal: Hepatology (Baltimore, Md.)
Published: July 29, 2015
A nontumorigenic variant of FGF19 treats cholestatic liver diseases.
Journal: Science translational medicine
Published: August 01, 2014
Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19.
Journal: Cancer research
Published: April 15, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026